Oncology Times: International Foundation Launched for CML

On 25 February 2010, the Oncology Times reported about the launch of the International CML Foundation (25 February 2010, Volume 32, Issue 4, pp 24-26, doi: 10.1097/01.COT.0000368857.22447.27). See the full text article here.

October is CML Awareness Month

On October 1st, The Max Foundation opens a global awareness campaign to support survivors around the world by uniting people everywhere in the fight against cancer. The campaign aims at reducing the feelings of isolation of people facing cancer in developing countries and elsewhere.

Saint-Petersburg, Russia

Andrey Zaritskey is Professor of hematology, Director of Institute of Oncohematology of Federal center of Heart, Blood and Endocrinology and lecture of Saint-Petersburg Pavlov state Medical University. He was graduated and post-graduated in Saint-Petersburg Pavlov State Medical University during 1967-1978 years. He has published more than 197 articles/abstracts in national and international journals. His scientific interest is the study of chronic myeloid leukemia and chronic lymphoproliferative neoplasms (chronic lymphocytic leukemia and Non-Hodgkin lymphomas), mesenchymal cell-haematopoietic cell interactions. He has been participating in nilotinib, dasatinib and bosutinib phase II and III international studies. He is one of the leaders in chronic myeloid and lymphatic leukemia in Russia, and deputy-chair of the scientific board of Russian Experts in chronic
myeloid leukemia.

Hematopoetic Stem Cell Transplantation in CML

Few examples in clinical medicine demonstrate such a fascinating interaction as chronic myeloid leukemia (CML) and hematopoietic stem cell transplantation (HSCT). CML did provide first proof of principle that an incurable disease was amenable to successful treatment, that immune mediated mechanism could control a malignancy and that the risk of HSCT could be quantified by a few key factors. HSCT was nearly abandoned at the introduction of targeted therapy with imatinib. Today, it has a clear position and exemplifies the modern risk adapted approach.

Caracas, Venezuela

Dr. Lopez is a Professor of Hematology and Internal Medicine at the "Universidad Central de Venezuela". Head of the Department of Hematology Clinics at the Banco Municipal de Sangre in Caracas, starting his work in this Institution in Hemato-Oncology Clinic at 1991 and developed the Molecular Dx Laboratory in 1992.

He occupied the Secretary position (2001-2003) at Venezuelan Society of Hematology and was a Founder Member of the National Transplant Organization of Venezuela.

Dr Lopez is an active member in the Investigation Department of his Medical Center and have been interested in Clinical Research and Molecular Genetic of Chronic Leukemias, collaborating like an Investigator Overseas in NCI-Cancer Therapy Evaluation Program (1995-1997).